Intel found the perfect window to raise capital, right after a +100% rally. The question is what existing shareholders pay for it. Intel is placing $15 billion in new shares to fund its AI infrastructure pivot. The timing is calculated: the restructuring rally gave the stock enough room to dilute without destroying the price. But dilution is dilution, every share issued today is a claim on future earnings that didn't exist yesterday. The chart shows the tension: $INTC at $96 today, down -3.34% on 101 million shares, one of the heaviest volume sessions of the year. The stock is pressing the $97–100 purple resistance zone that has capped every recovery attempt. MACD just crossing green but RSI at 43–46, the signal is early and unconfirmed. The strategic read: $15B goes toward foundry capacity and AI chip development to compete with $NVDA and $AMD. If Intel executes, the dilution is forgettable. If it doesn't, and execution has been Intel's problem for years, shareholders just funded another missed cycle. $100 is the first real resistance above. Lose $90 and the cuña descendente resumes toward $84. The Apple foundry deal and the $15B raise live or die together. Dilution as investment or dilution as desperation, which one is Intel doing at $98? 👇
172 views
0 Comments
Join the conversation with 500,000+ other investors 💸
Create an account to get access to everything Blossom has to offer!
📊 Personalized algorithm based on your investing style, experience level and interests
📈 Powerful portfolio and dividend tracking tools
👀 See what top creators and others in the community are investing in
